Genetic research
Research Reveals Higher Risk of Metastasis in Non-Small Cell Lung Cancer Patients with HER2 Exon 20 Mutations
Researchers at Maoming People's Hospital conducted a study to investigate the clinical and genetic characteristics of HER2 exon 20 oncogenic variants in non-small cell lung cancer (NSCLC) patients. The study analyzed 51 NSCLC patients with HER2 mutations, identifying 20 (39.3%) with exon 20 mutations. These patients showed